Fungal Keratitis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Fungal keratitis, also known as
mycotic keratitis, is a severe sight-threatening condition. This highly
damaging corneal infection often leads to permanent blindness and eye loss.
Fungal keratitis tends to be a poorly treated condition with very high morbidity.
Fungal keratitis occurs secondary to usually minor ocular trauma in most cases.
~ 4% of patients were found in children, although most cases are seen in adults
aged 20–50 years. Other reported predisposing factors for filamentous fungal
keratitis include previous ocular surgery, ocular surface disease, contact lens
use, previous use of corticosteroids (topical or systemic), and
immunosuppressive conditions such as HIV/AIDS. Fungal keratitis (FK) often
poses significant diagnostic and therapeutic dilemmas. It is most commonly
observed in tropical/subtropical countries and regions with prevalent
agricultural activity, accounting for 23–63% of all FK cases in these regions.
Most of the patients were found to have at least one risk factor, with ocular
surface disease (51.3%), prior corneal surgery (37.6%), and systemic
immunosuppression (35.9%).
- Fungal keratitis (FK) represents the leading cause of corneal
blindness globally, with an estimated incidence of 64 to 87 cases per
100,000 population in the USA.
Thelansis’s “Fungal Keratitis Market
Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Fungal
Keratitis treatment modalities options for eight major markets (USA, Germany,
France, Italy, Spain, UK, Japan, and China).
KOLs insights
of Fungal Keratitis across 8 MM market from the centre of Excellence/ Public/
Private hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Fungal Keratitis Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment